BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

EFAVIRENZ Pages on BioPortfolio:

Biotechnology News EFAVIRENZ Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/EFAVIRENZ-news.htm...

BioPortfolio - Efavirenz
Efavirenz - BioPortfolio - Indepth. ... Efavirenz. Efavirenz. Download PDF containing detailed information. PDF Version ...
http://www.bioportfolio.com/indepth/Efavirenz.html...

BioPortfolio Biotechnology BioNews : live article
Results were comparable for patients taking the efavirenz combination, ... Baseline HIV RNA for patients in the efavirenz arm of the study was 67554 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - Lamivudine - InDepth
Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, ... Fasted Lipid Changes after Administration of Maraviroc or Efavirenz, ...
http://www.bioportfolio.com/indepth/Lamivudine.pdf...

BioPortfolio Biotechnology BioNews : live article
Truvada and Sustiva are also available in the United States as the fixed-dose product Atripla(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - CYP2B6 publications
The 516G > T allele is associated with a defective metabolism of efavirenz (EFV) , which therefore may predispose to drug toxicity. ...
http://www.bioportfolio.com/gene/1555-CYP2B6/publications.ht...

Biotechnology News LAMIVUDINE Search
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate Tablets ...
http://www.bioportfolio.co.uk/LAMIVUDINE-news.htm...

BioPortfolio - CYP2B6 - cytochrome P450, family 2, subfamily B ...
Smoking and Drinking Alcohol Linked to Lower Efavirenz Levels ... Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics ...
http://www.bioportfolio.com/gene/1555-CYP2B6.html...

BioPortfolio Biotechnology BioNews : live article
Sustiva (efavirenz) is marketed in the United States, Canada and certain European ... Elsewhere in the world, efavirenz is marketed by Merck & Co., Inc.,
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - Matrix Laboratories Limited - Profile
Validated enantiospecific LC method for determination of (R)-enantiomer impurity in (S)-efavirenz. A high-performance liquid chromatographic method was ...
http://www.bioportfolio.com/biocorporate/26043-Matrix%252525...

Results from other life science and pharmaceutical sites:

Efavirenz - Wikipedia, the free encyclopedia
Efavirenz (brand names Sustiva and Stocrin) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active
antiretroviral ...
http://en.wikipedia.org/wiki/Efavirenz...

AIDSinfo - HIV/AIDS Drug Information - Efavirenz
Efavirenz, also known as EFV or Sustiva, is a type of medicine called a non- nucleoside reverse transcriptase inhibitor (NNRTI). ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?int_i...

Pharmacogenetics of plasma efavirenz exposure after treatment ...
BACKGROUND: Efavirenz has a long plasma half-life and a low genetic barrier to resistance. Simultaneously stopping treatment with all agents in ...
http://www.ncbi.nlm.nih.gov/pubmed/16392089...

AIDSinfo - HIV/AIDS Drug Information - Efavirenz / Emtricitabine ...
Efavirenz is a type of medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). Both emtricitabine and tenofovir DF are medicines called ...
http://www.aidsinfo.nih.gov/drugsNew/DrugDetailNT.aspx?MenuI...

Triple-nucleoside regimens versus efavirenz-containing regimens ...
After a median follow-up of 32 weeks, 82 of 382 subjects in the triple- nucleoside group (21 percent) and 85 of 765 of those in the combined efavirenz
groups ...
http://www.ncbi.nlm.nih.gov/pubmed/15115831...

Efavirenz: MedlinePlus Drug Information
Efavirenz is used with other medications to treat human immunodeficiency virus ( HIV) infection in patients with or without acquired immunodeficiency ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a699004.htm...

Substitution of nevirapine, efavirenz, or abacavir for protease ...
BACKGROUND: We assessed the strategy of substituting nevirapine, efavirenz, or abacavir for a protease inhibitor in patients infected with human ...
http://www.ncbi.nlm.nih.gov/pubmed/12968087...

AIDSinfo - HIV/AIDS Drug Information - Efavirenz / Emtricitabine ...
12 Jul 2006 ... One tablet of Atripla is equivalent to one tablet of efavirenz 600 mg, a non- nucleoside reverse transcriptase inhibitor (NNRTI), ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailT.aspx?int_id...

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir ...
BACKGROUND: Efavirenz is a nonnucleoside reverse-transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). We compared two regimens containing
...
http://www.ncbi.nlm.nih.gov/pubmed/10601505...

Resistance to efavirenz (SUSTIVA) in vivo.
Efavirenz (SUSTIVA, DMP 266) is a potent inhibitor of the reverse transcriptase of HIV-1. In order to assess the potential for the development of resistance ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102236281.html...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.